CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $319,000
- in 1 filing
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-18 | Yonehiro Grant Chief Operating Officer | Sale | −6,850 | $3.24 | $22K | 17,269 |
| 2026-09-18 | Nemec Sarah Senior VP, Finance and PAO | Sale | −4,077 | $3.24 | $13K | 17,082 |
| 2026-09-18 | Quinn William P. President, CEO and CFO | Sale | −9,132 | $3.24 | $30K | 25,384 |
| 2026-09-17 | Yonehiro Grant Chief Operating Officer | Sale | −4,909 | $3.32 | $16K | 24,119 |
| 2026-09-17 | Nemec Sarah Senior VP, Finance and PAO | Sale | −2,922 | $3.32 | $10K | 21,159 |
| 2026-09-17 | Quinn William P. President, CEO and CFO | Sale | −6,545 | $3.32 | $22K | 34,516 |
| 2026-09-16 | Yonehiro Grant Chief Operating Officer | Sale | −1,417 | $3.77 | $5K | 29,028 |
| 2026-09-16 | Nemec Sarah Senior VP, Finance and PAO | Sale | −843 | $3.77 | $3K | 24,081 |
| 2026-09-16 | Quinn William P. President, CEO and CFO | Sale | −1,889 | $3.77 | $7K | 41,061 |
| 2023-11-30 | ENGLEMAN EDGAR Director | Sale | −108,145 | $0.86 | $93K | 1,821,483 |
| 2023-11-30 | ENGLEMAN EDGAR Director | Sale | −14,934 | $0.86 | $13K | 251,522 |
| 2023-11-29 | ENGLEMAN EDGAR Director | Sale | −22,674 | $0.91 | $21K | 1,929,628 |
| 2023-11-29 | ENGLEMAN EDGAR Director | Sale | −3,131 | $0.91 | $3K | 266,456 |
| 2023-11-21 | Vivo Capital VIII, LLC 10% owner | Sale | −1,707 | $0.90 | $2K | 1,952,302 |
| 2023-11-21 | Vivo Capital VIII, LLC 10% owner | Sale | −236 | $0.90 | $212 | 269,587 |
| 2023-11-21 | Vivo Capital VIII, LLC 10% owner | Sale | −1,457 | $0.90 | $1K | 111,662 |
| 2023-11-21 | ENGLEMAN EDGAR Director | Sale | −1,707 | $0.90 | $2K | 1,952,302 |
| 2023-11-21 | ENGLEMAN EDGAR Director | Sale | −236 | $0.90 | $213 | 269,587 |
| 2023-11-20 | Vivo Capital VIII, LLC 10% owner | Sale | −27,465 | $0.92 | $25K | 1,954,009 |
| 2023-11-20 | Vivo Capital VIII, LLC 10% owner | Sale | −3,792 | $0.92 | $3K | 269,823 |
Page 1 of 2 · 40 trades